Compound Detail
CHEMBL168811
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CC(C(=O)C1c2cccc(O)c2C(=O)c2c(O)cccc21)c1ccc(C(=O)c2ccccc2)cc1
Basic Information
| ChEMBL ID | CHEMBL168811 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ZTMJNVOWAURVHX-UHFFFAOYSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
462.5
MW (Da)
5.38
ALogP
5
HBA
2
HBD
91.7
PSA (Ų)
0.39
QED
1
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 6.05
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| ADMET | IC50 | = | 900.0 | nM | 6.05 | Concentration required to inhibit 50% growth of HaCaT cells | 11262091 |
| Unchecked | IC50 | = | 9000.0 | nM | 5.05 | Inhibition of LTB4 biosynthesis in bovine polymorphonuclear leukocytes using nor... | 11262091 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 11262091 | 10.1021/jm001073w | Unchecked | 2 |
| 11262091 | 10.1021/jm001073w | ADMET | 2 |
| 11262091 | 10.1021/jm001073w | No relevant target | 1 |
Data from ChEMBL 36 via Core Engine